A lymphokine activated killer (LAK) cell assay has been developed utilizing a clonogenic microassay in agar-containing capillaries with KB tumor goal cells. The assay avoids

Expression Pathology Inc. (EPI) Biotechnology
Multiplex tissue proteomic assays using FFPE IHC analysis